Catarina Edfjäll
Plus aucun poste en cours
Fortune : - $ au 31/03/2024
Profil
Catarina Edfjäll formerly worked at The Cancer Drug Development Forum, as Director from 2008 to 2012, International Collaboration On Rare Diseases & Orphan Drugs, as Director from 2014 to 2021, ObsEva SA, as Independent Director from 2021 to 2024, and CSL Behring AG, as Global Head-Regulatory Affairs from 2013 to 2019.
Dr. Edfjäll received her doctorate degree from the University of Basel and graduate degree from the University of Strasbourg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OBSEVA SA
-.--% | 24/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Anciens postes connus de Catarina Edfjäll
| Sociétés | Poste | Fin |
|---|---|---|
| OBSEVA SA | Director/Board Member | 18/03/2024 |
| International Collaboration On Rare Diseases & Orphan Drugs | Director/Board Member | 01/01/2021 |
CSL Behring AG
 CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The private company is based in Bern, Switzerland. | General Counsel | 01/01/2019 |
| The Cancer Drug Development Forum | Director/Board Member | 01/01/2012 |
Formation de Catarina Edfjäll
| University of Basel | Doctorate Degree |
| University of Strasbourg | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OBSEVA SA | Health Technology |
| Entreprise privées | 3 |
|---|---|
CSL Behring AG
CSL Behring AG BiotechnologyHealth Technology Part of CSL Ltd., CSL Behring AG is a Swiss company that develops biological products. The private company is based in Bern, Switzerland. | Health Technology |
| The Cancer Drug Development Forum | |
| International Collaboration On Rare Diseases & Orphan Drugs |
